CD44 and malignant colon neoplasm: More recently, Nautiyal et al. [31] reported that a combination of curcumin and the chemotherapeutic agent dasatinib eliminates mRNA stem cell markers—specifically, ALDH, CD44, CD133, and CD166—that are enriched in the chemo-resistant colon cancer cells.